Fundz

Terumo Corporation acquires OrganOx Ltd.

Oct 30, 2025

Acquiring Company

Terumo

Acquired Company

OrganOx

Minato CityOxfordshireBiotechnologyHealth CareMedicalMedical Devicemedical devicesBiotechnologyHealth Care

Description

On October 30, 2025, OrganOx announced its acquisition by Terumo Corporation after fulfilling regulatory conditions. OrganOx will now function as a wholly owned subsidiary, aiming to expand its organ perfusion technology. This acquisition will enhance research, development, and market presence for both companies in the organ transplantation field.

Quick answer

Terumo is acquiring OrganOx, announced October 30, 2025. Terumo is based in Minato City, Tokyo, Japan.

How much did Terumo pay for OrganOx?
The deal value was not disclosed.
What does Terumo do?
Terumo is a global leader in medical technology and has been committed to "Contributing to Society through Healthcare" for 100 years.
Where are Terumo and OrganOx based?
Terumo is based in Minato City, Tokyo, Japan. OrganOx is based in Oxfordshire, England, United Kingdom.
Who are the decision-makers at Terumo?
Fundz holds 1 contact at Terumo. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Other recent acquisitions in Medical and Medical Device

Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.

Who to call at Terumo, and when

When Terumo changes hands, the new owners review vendors, systems and leadership. That is when the door opens.

  • An alert the day Terumo raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Terumo, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Terumo. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Terumo

Location

Minato City, Tokyo, Japan

About

Terumo is a global leader in medical technology and has been committed to "Contributing to Society through Healthcare" for 100 years. Based in Tokyo and operating globally, Terumo employs more than 30,000 associates worldwide to provide innovative medical solutions in more than 160 countries and regions. The company started as a Japanese thermometer manufacturer and has been supporting healthcare ever since. Now, its extensive business portfolio ranges from vascular intervention and cardio-surgical solutions, blood transfusion and cell therapy technology, to medical products essential for daily clinical practice such as transfusion systems, diabetes care, and peritoneal dialysis treatments. Terumo will further strive to be of value to patients, medical professionals, and society at large.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Terumo makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Ryosuke
Likely contact at this company
••••••••@••••••••

See Ryosuke's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Terumo's next move

Learn about Strategic plan

Frequently asked

Who acquired OrganOx?

OrganOx was acquired by Terumo, based in Minato City. The deal was reported on October 30, 2025. Terumo is a global leader in medical technology and has been committed to "Contributing to Society through Healthcare" for 100 years. Terumo is privately held and operates in Biotechnology.

When did Terumo acquire OrganOx?

Terumo's acquisition of OrganOx was reported on October 30, 2025. On October 30, 2025, OrganOx announced its acquisition by Terumo Corporation after fulfilling regulatory conditions. OrganOx will now function as a wholly owned subsidiary, aiming to expand its organ perfusion technology. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does OrganOx do?

OrganOx Limited is a medical technology company dedicated to improving organ transplant outcomes through its advanced organ preservation solutions. The company develops devices that enhance the viability and health of organs before transplantation. It is privately held, operating in Biotechnology, and is based in Oxfordshire.

This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.